Metoclopramide Hydrochloride Metoclopramide Hydrochloride 5mg/5ml Oral Solution

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Hydrochloride 5mg/5ml Oral Solution, is a dopamine antagonist (antiemetic) presented as a 5 mg per 5 ml oral solution for oral use. It treats nausea, vomiting, post‑operative nausea, gastroparesis and chemotherapy‑induced nausea in adults.

GNH USA supplies Metoclopramide Hydrochloride 5mg/5ml Oral Solution as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that trigger nausea and on gastrointestinal motility, making it useful in several related conditions. - Nausea and vomiting: reduces frequency and severity of episodes. - Post‑operative nausea and vomiting: prevents and treats symptoms after surgery. - Gastroparesis: enhances gastric emptying and relieves associated discomfort. - Chemotherapy‑induced nausea: alleviates nausea caused by cytotoxic drugs.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness - Fatigue - Restlessness or agitation - Diarrhoea - Headache - Dry mouth

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., dystonia, akathisia) - Tardive dyskinesia with long‑term use - Neuroleptic malignant syndrome - Depression or suicidal thoughts - Seizures - Cardiac arrhythmias

Before prescribing Metoclopramide, clinicians should consider several safety aspects. - Assess neurological status: monitor for extrapyramidal symptoms. - Review medication history: avoid concurrent use with other dopamine antagonists. - Consider renal function: dose adjustment may be needed in severe impairment. - Use caution in elderly: increased risk of sedation and falls. - Avoid in patients with known hypersensitivity to metoclopramide. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Metoclopramide can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may increase anticholinergic burden. - CYP2D6 inhibitors (e.g., fluoxetine): increase metoclopramide plasma levels. - Other dopamine antagonists: additive risk of extrapyramidal effects. - MAO inhibitors: risk of hypertensive crisis. - Serotonergic agents: potential for serotonin syndrome.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., opioids, alcohol): enhanced sedation. - Antihistamines: may increase drowsiness. - Diuretics: may potentiate electrolyte disturbances.